Annual SGA
$88.43 M
-$1.55 M-1.72%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual SGA is $88.43 million, with the most recent change of -$1.55 million (-1.72%) on December 31, 2023.
- During the last 3 years, PBYI annual SGA has fallen by -$30.06 million (-25.37%).
- PBYI annual SGA is now -39.50% below its all-time high of $146.17 million, reached on December 31, 2018.
Performance
PBYI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$16.87 M
-$8.29 M-32.95%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly SGA is $16.87 million, with the most recent change of -$8.29 million (-32.95%) on September 30, 2024.
- Over the past year, PBYI quarterly SGA has dropped by -$5.31 million (-23.94%).
- PBYI quarterly SGA is now -62.93% below its all-time high of $45.51 million, reached on March 31, 2019.
Performance
PBYI Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$5.38 B
+$23.24 M+0.43%
September 30, 2024
Summary
- As of February 7, 2025, PBYI TTM SGA is -$5.38 billion, with the most recent change of +$23.24 million (+0.43%) on September 30, 2024.
- Over the past year, PBYI TTM SGA has dropped by -$5.48 billion (-5848.96%).
- PBYI TTM SGA is now -18437715.07% below its all-time high of -$29.20 thousand.
Performance
PBYI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PBYI Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.7% | -23.9% | -5849.0% |
| 3 y3 years | -25.4% | -18.0% | -6113.9% |
| 5 y5 years | -39.5% | -18.0% | -6113.9% |
PBYI Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.0% | at low | -33.0% | at low | at high | +1.6% |
| 5 y | 5-year | -37.6% | at low | -57.2% | at low | -7.5% | +1.6% |
| alltime | all time | -39.5% | >+9999.0% | -62.9% | >+9999.0% | <-9999.0% | +1.6% |
Puma Biotechnology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.87 M(-32.9%) | $83.48 M(-6.0%) |
| Jun 2024 | - | $25.16 M(+16.2%) | $88.79 M(+1.4%) |
| Mar 2024 | - | $21.64 M(+9.2%) | $87.58 M(-1.0%) |
| Dec 2023 | $88.43 M(-1.7%) | $19.82 M(-10.6%) | $88.43 M(-5.6%) |
| Sep 2023 | - | $22.18 M(-7.4%) | $93.65 M(-1.9%) |
| Jun 2023 | - | $23.95 M(+6.5%) | $95.43 M(+3.7%) |
| Mar 2023 | - | $22.49 M(-10.2%) | $92.06 M(+2.3%) |
| Dec 2022 | $89.98 M(-22.6%) | $25.04 M(+4.5%) | $89.98 M(+2.9%) |
| Sep 2022 | - | $23.96 M(+16.5%) | $87.40 M(-2.4%) |
| Jun 2022 | - | $20.58 M(+0.9%) | $89.52 M(-17.4%) |
| Mar 2022 | - | $20.40 M(-9.2%) | $108.36 M(-6.7%) |
| Dec 2021 | $116.29 M(-1.9%) | $22.46 M(-13.9%) | $116.19 M(-5.0%) |
| Sep 2021 | - | $26.08 M(-33.8%) | $122.34 M(-2.8%) |
| Jun 2021 | - | $39.41 M(+39.6%) | $125.85 M(+8.7%) |
| Mar 2021 | - | $28.24 M(-1.3%) | $115.79 M(-2.3%) |
| Dec 2020 | $118.49 M(-16.3%) | $28.61 M(-3.4%) | $118.49 M(-2.1%) |
| Sep 2020 | - | $29.60 M(+0.9%) | $121.09 M(-1.5%) |
| Jun 2020 | - | $29.35 M(-5.1%) | $122.89 M(-3.3%) |
| Mar 2020 | - | $30.94 M(-0.9%) | $127.07 M(-10.3%) |
| Dec 2019 | $141.64 M(-3.1%) | $31.20 M(-0.6%) | $141.64 M(-6.4%) |
| Sep 2019 | - | $31.40 M(-6.3%) | $151.37 M(+2.0%) |
| Jun 2019 | - | $33.53 M(-26.3%) | $148.47 M(-4.3%) |
| Mar 2019 | - | $45.51 M(+11.2%) | $155.07 M(+6.1%) |
| Dec 2018 | $146.17 M(+37.0%) | $40.93 M(+43.6%) | $146.17 M(+7.4%) |
| Sep 2018 | - | $28.50 M(-29.0%) | $136.11 M(-2.8%) |
| Jun 2018 | - | $40.13 M(+9.7%) | $140.10 M(+12.2%) |
| Mar 2018 | - | $36.60 M(+18.6%) | $124.89 M(+17.1%) |
| Dec 2017 | $106.69 M(+98.3%) | $30.87 M(-5.0%) | $106.69 M(+15.6%) |
| Sep 2017 | - | $32.49 M(+30.3%) | $92.29 M(+25.0%) |
| Jun 2017 | - | $24.93 M(+35.5%) | $73.82 M(+20.7%) |
| Mar 2017 | - | $18.40 M(+11.7%) | $61.16 M(+13.7%) |
| Dec 2016 | $53.80 M | $16.47 M(+17.5%) | $53.80 M(+14.7%) |
| Sep 2016 | - | $14.02 M(+14.3%) | $46.92 M(+12.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $12.27 M(+11.1%) | $41.71 M(+19.3%) |
| Mar 2016 | - | $11.04 M(+15.0%) | $34.98 M(+10.0%) |
| Dec 2015 | $31.81 M(+64.3%) | $9.60 M(+8.9%) | $31.81 M(+5.1%) |
| Sep 2015 | - | $8.81 M(+59.2%) | $30.27 M(+19.5%) |
| Jun 2015 | - | $5.53 M(-29.7%) | $25.33 M(+6.9%) |
| Mar 2015 | - | $7.87 M(-2.4%) | $23.70 M(+22.5%) |
| Dec 2014 | $19.36 M(+97.8%) | $8.06 M(+108.5%) | $19.36 M(+35.6%) |
| Sep 2014 | - | $3.87 M(-0.9%) | $14.28 M(+12.7%) |
| Jun 2014 | - | $3.90 M(+10.8%) | $12.68 M(+14.8%) |
| Mar 2014 | - | $3.52 M(+18.2%) | $11.04 M(+12.8%) |
| Dec 2013 | $9.79 M(-60.6%) | $2.98 M(+31.8%) | $9.79 M(-52.2%) |
| Sep 2013 | - | $2.26 M(-0.2%) | $20.47 M(-22.2%) |
| Jun 2013 | - | $2.27 M(-0.3%) | $26.30 M(+1.9%) |
| Mar 2013 | - | $2.27 M(-83.4%) | $25.80 M(+4.0%) |
| Dec 2012 | $24.81 M(+165.9%) | $13.66 M(+68.8%) | $24.81 M(+23.4%) |
| Sep 2012 | - | $8.09 M(+357.0%) | $20.11 M(+62.8%) |
| Jun 2012 | - | $1.77 M(+37.9%) | $12.35 M(+16.4%) |
| Mar 2012 | - | $1.28 M(-85.7%) | $10.61 M(+13.7%) |
| Dec 2011 | $9.33 M(>+9900.0%) | $8.96 M(+2584.0%) | $9.33 M(+2409.7%) |
| Sep 2011 | - | $333.80 K(+878.9%) | $371.80 K(+878.4%) |
| Jun 2011 | - | $34.10 K(+774.4%) | $38.00 K(+503.2%) |
| Mar 2011 | - | $3900.00(+62.5%) | $6300.00(-54.0%) |
| Dec 2010 | $7000.00(-58.3%) | - | - |
| Jun 2010 | - | $2400.00(-48.9%) | $13.70 K(-11.6%) |
| Mar 2010 | - | $4700.00(+42.4%) | $15.50 K(-7.7%) |
| Dec 2009 | $16.80 K(+19.1%) | $3300.00(0.0%) | $16.80 K(+7.0%) |
| Sep 2009 | - | $3300.00(-21.4%) | $15.70 K(-4.3%) |
| Jun 2009 | - | $4200.00(-30.0%) | $16.40 K(+5.1%) |
| Mar 2009 | - | $6000.00(+172.7%) | $15.60 K(+10.6%) |
| Dec 2008 | $14.10 K | $2200.00(-45.0%) | $14.10 K(+18.5%) |
| Sep 2008 | - | $4000.00(+17.6%) | $11.90 K(+50.6%) |
| Jun 2008 | - | $3400.00(-24.4%) | $7900.00(+75.6%) |
| Mar 2008 | - | $4500.00 | $4500.00 |
FAQ
- What is Puma Biotechnology annual SGA?
- What is the all time high annual SGA for Puma Biotechnology?
- What is Puma Biotechnology annual SGA year-on-year change?
- What is Puma Biotechnology quarterly SGA?
- What is the all time high quarterly SGA for Puma Biotechnology?
- What is Puma Biotechnology quarterly SGA year-on-year change?
- What is Puma Biotechnology TTM SGA?
- What is the all time high TTM SGA for Puma Biotechnology?
- What is Puma Biotechnology TTM SGA year-on-year change?
What is Puma Biotechnology annual SGA?
The current annual SGA of PBYI is $88.43 M
What is the all time high annual SGA for Puma Biotechnology?
Puma Biotechnology all-time high annual SGA is $146.17 M
What is Puma Biotechnology annual SGA year-on-year change?
Over the past year, PBYI annual SGA has changed by -$1.55 M (-1.72%)
What is Puma Biotechnology quarterly SGA?
The current quarterly SGA of PBYI is $16.87 M
What is the all time high quarterly SGA for Puma Biotechnology?
Puma Biotechnology all-time high quarterly SGA is $45.51 M
What is Puma Biotechnology quarterly SGA year-on-year change?
Over the past year, PBYI quarterly SGA has changed by -$5.31 M (-23.94%)
What is Puma Biotechnology TTM SGA?
The current TTM SGA of PBYI is -$5.38 B
What is the all time high TTM SGA for Puma Biotechnology?
Puma Biotechnology all-time high TTM SGA is -$29.20 K
What is Puma Biotechnology TTM SGA year-on-year change?
Over the past year, PBYI TTM SGA has changed by -$5.48 B (-5848.96%)